chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Polio; stopped breathing; paralyzed from the waist down; Initial information received on 08-Oct-2020 regarding an unsolicited valid serious case received from a consumer or non-healthcare professional.   This case involves a patient (unknown demographics) who experienced polio (poliomyelitis), paralyzed from  the waist down (paraplegia) and stopped breathing (dyspnoea), when received POLIOMYELITIS VACCINE (INACTIVATED).  Concomitant medications included BENZYLPENICILLIN from which the patient almost died.  The patient's medical history, past medical treatment, vaccination and family history were not provided.   On an unknown date, the patient received a dose of suspect POLIOMYELITIS VACCINE (INACTIVATED) produced by unknown manufacturer (batch number and expiry date not reported) via an unknown route at unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed polio (poliomyelitis), paralyzed from  the waist down (paraplegia) and stopped breathing (dyspnoea) unknown latency following the administration of POLIOMYELITIS VACCINE (INACTIVATED).   Event poliomyelitis and paraplegia was assessed as medically significant.  Intensity of polio event was mild.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment.  On an unknown date, the patient recovered from paraplegia (paralyzed from the waist down for a week).  The event outcome was unknown for poliomyelitis and dyspnoea.  Batch number has been requested for suspect product for this case.; Sender's Comments: This case reported from Facebook involved patient (unknown demographics) who presented with poliomyelitis and dyspnoea following the vaccination with POLIOMYELITIS VACCINE. The time to onset is unknown. Medical history, concomitant medication include PENICILLIN shot, and precise final diagnosis and lab data ruling out alternative etiologies were not reported. Based upon the reported information, role the vaccine cannot be assessed.
12/31/2021, congestion in head and had scratchy throat that cause you to take a COVID test a 01/01/2022 test at home test Quick view 01/02/2022 both COVID positive and called physician on 01/01/2022 for directives for care. Nurse practitioner returned her call out and gave her directives for at home care of vitamins, and fluids. Fatigue, headache and scratchy throat and congestion, although recover from most symptoms the fatigue continues to linger. A wave of fatigue would occur.
arm was in pain; Painful rash; This is a spontaneous report from a contactable consumer. A 75-years-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EN5318), via an unspecified route of administration, administered in Arm Left on 01Feb2021 15:00 PM as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history included Hemochromatosis (gets phlebotomy due to excess iron) and high blood pressure from an unknown date and unknown if ongoing. Concomitant medications included diltiazem (DILTIAZEM) taken for blood pressure abnormal from an unspecified start date and ongoing; acetylsalicylic acid (BABY ASPIRIN) and ergocalciferol, retinol palmitate (VITAMINS A & D) taken for an unspecified indication, start and stop date were not reported. The patient previously took prednisone and cortisone and experienced allergy. (She is allergic to steroids. She knows she is allergic to Prednisone and Cortisone.) The patient previously received a flu shot on an unspecified date many years ago and she has had normal fever a day after the vaccine. She stopped taking the flu vaccine. She had the first COVID19 vaccine on 01Feb2021. The next day her arm was in pain and that went away that day. She also developed a rash; it was like bumps. She went to the doctor and he said it was eczema. Caller states it is not eczema. It spread all over the body. She is concerned so she is calling. It is over a week and she still have some rash. Her concern is if she should take the second vaccine if this one made her this ill. The rash is a little less, it wasn't so much itchy as it was painful. The doctor gave her an ointment to put on the rash. It did nothing. The cream is Triamcinolone Acetonide 0.1 percent, (Lot: 1014221, expiry: Jul2022). The outcome of the event pain in arm was recovered and outcome for event painful rash was recovering.  Follow-up attempts are completed. No further information is expected.
After the vaccination pt said that she might faint because it happened before with another vaccine. She indicated that she would be alright. About two minutes after sitting down she fell on the ground. after helping her by laying her down on the ground and later sitting up she was okay. She mentioned that she had this vaccine when she was 11 years old and she didn't faint from it. She said in the past she fainted with the Gardisil vaccine. After sitting down to rest she was okay after.
Around evening, couldn't move LA, felt sore. 100mg CELEBREX 2x. Pennsade? muscle relaxer. Overnight, cold and fever. Next day 100mg CELEBREX 2x and 1000mg TYLENOL.
Suspected Vaccination failure; had shingles for about "4 years" now. "2 years ago" / received / vaccine / Shingles never went away / began to occur more frequently / experience shingles every 2 months; had shingles for about "4 years" now. "2 years ago" / received / vaccine / Shingles never went away / began to occur more frequently / experience shingles every 2 months; This case was reported by a consumer via other manufacturer and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (since about 4 years from the time of reporting).   On an unknown date, the patient received Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and condition aggravated. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and condition aggravated were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and condition aggravated to be related to Shingrix.  Additional details were provided as follows The age at vaccination was not reported. The patient had shingles for about 4 years from the date of reporting. The patient received Shingrix 2 years ago from the date of reporting. After receiving Shingles vaccine, her shingles never went away. They even began to occur more frequently, because she started to experience shingles every 2 months.  No additional adverse events information was reported.  No product quality complaint was reported. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
Received flu mist seasonal vaccine 10/13/09. Woke up next AM covered with hives, itching. Relieved with BENADRYL.
Chills that were worse than the first time for about 4 hrs.  Mild headache next day.
The night of shot was awaken by severe pain in chest at 2:30AM couldn't hardly breathe. Also within 2 days have a red/bumpy rash on injection site. Swollen and very sore.
Breakthrough case: I contracted COVID-19. My symptoms included fever, headache, stuffiness, body aches, sore throat, and joint pain. I received the monoclonal antibody infusion as treatment.
Fully vaccinated patient hospitalized with positive COVID PCR.  Patient admitted from ED after a  fall at home on 05/20/21 which patient attributed to weakness.  COVID swab in ED for admission testing was positive for COVID.  Weakness only notable symptom at that time.  Patient d/c'd home and readmitted on 05/28/21 per recommendation of Homecare due to increased shortness of breath and O2 in 70's.  Chest X-ray showed PNA.  Patient discharged with Homecare on 06/02/21.
Presented to the ED with shortness of breath, diarrhea, urinary symptoms, body aches, O2 is 60% Was given decadron, symbicort, and oxygen Discharged under stable conditions
Severe swelling extending from the top of the shoulder to the elbow, area hot puffy and red for 5 days.  Site still painful and patient is running a fever and has a runny nose.  Mother consulted physician and has been treating with acetaminophen and drinking more water.  While still painful at day 5 the swelling has gone down.
No adverse effects reported; a dose of expired varivax was inadvertently administered to the patient; This spontaneous report was received from a nurse, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies and concurrent conditions were not reported.  On 06-OCT-2020, the patient was inadvertently vaccinated with an expired dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # R027993, expiration date 01-OCT-2020, for prophylaxis (strength, dose, route and frequency were not reported). No adverse effects reported.
Pain in neck after 2nd dose; Pain in arm after 2nd dose; Pain in shoulder after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN, PAIN IN EXTREMITY, and ARTHRALGIA in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NECK PAIN, PAIN IN EXTREMITY, and ARTHRALGIA. At the time of the report, NECK PAIN, PAIN IN EXTREMITY, and ARTHRALGIA outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Within 15 minutes, I started to feel dizzy, then numbness in my face, hands and legs. I then started to feel sweaty and my hands were ice cold at the same time as feeling sweaty. The pharmacist called 911.  I was taken by ambulance to the hospital.  An IV was started in the ambulance, and I was given oxygen because I started to feel nausueous. At the hospital I was given an IV, and something for nausea then sent home.
About three weeks after receiving the vaccine she experienced an ear infection. She woke up with a fever. We took her to Urgent Care. She was diagnosed with a double ear infection. She was given an antibiotic, cefdinir, and we are following up with her pediatrician on September 1st. Her brother received the same vaccine on the same day, same lot number, and did not have any adverse events.
Several menstrual (post-menopausal) bleeding ,still bleeding; still bleeding; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of POSTMENOPAUSAL HAEMORRHAGE (Several menstrual (post-menopausal) bleeding ,still bleeding) and HAEMORRHAGE (still bleeding) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced POSTMENOPAUSAL HAEMORRHAGE (Several menstrual (post-menopausal) bleeding ,still bleeding) (seriousness criterion medically significant) and HAEMORRHAGE (still bleeding) (seriousness criterion medically significant). At the time of the report, POSTMENOPAUSAL HAEMORRHAGE (Several menstrual (post-menopausal) bleeding ,still bleeding) and HAEMORRHAGE (still bleeding) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment for the events were not provided. this is a valid case  Company Comment : Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.no further information is available for this case.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.no further information is available for this case.
11/28/21 presents to ED for "chest tightness" "SOB with cough and fever". PMHx of "obesity and osteoarhtritis"
Guest was here to receive his second dose of the Moderna vaccine.  This was day 28 from first dose. Guest  received the Pfizer vaccine instead.  Guest did not notice it until he had left the building.  He returned to report the mistake. He did not report any ill effects. Stated he felt good.
Throbbing/tension headache around and above eyes level, arms/legs muscle ache last for 2 days that did not go away when taking Tylenol 500mg.
deathly ill; Initial information regarding this unsolicited valid serious social media case received from a consumer (patient's child) and transmitted to Sanofi on 08-Dec-2020.  This case involved a male patient of unknown age who was deathly ill (illness), after he received vaccine INFLUENZA VACCINE.  Relevant medical history, past medical treatment, vaccination details, family history and concomitant medications were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, it was reported that the patient was in the hospital for two weeks being deathly ill (illness) (unknown latency) following the administration of INFLUENZA VACCINE. The patient's child reported that the doctor had said that it was due to the INFLUENZA VACCINE that the patient had received.   Relevant laboratory test was not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome was unknown for the reported event.  There would be no information available on batch number for this case.; Sender's Comments: This case concerns a male patient of unknown age who had presented with illness after vaccination with INFLUENZA VACCINE produced by unknown manufacturer. The time to onset is unknown. Moreover, patient's medical condition, concomitant medication and laboratory tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the vaccine cannot be assessed.
This spontaneous report as received from a physician refers to a 17 year old patient of unknown gender. No information on the patient's concurrent conditions, medical history and concomitant medications was reported. On 15-AUG-2017, the patient was vaccinated with improperly stored GARDASIL 9 lot # M040412, expiry date 30-JUN-2019 (dose, route of administration were not provided). Data logger was not involved. No adverse event was reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA012770: US-009507513-1709USA012767: US-009507513-1709USA012768: US-009507513-1709USA012769: US-009507513-1709USA012765: US-009507513-1709USA007325: US-009507513-1709USA012766: US-009507513-1709USA012764.
Onsite reaction, injection site is red and swollen for past days. Referred to her doctor.
SYSTEMIC HIVES. STARTED UNDERSIDE UPPER LEFT ARM AND BELOW ARMPIT. EXPANDED OVER 3 DAYS LEFT TO RIGHT AND TOP TO BOTTOM TO ARMS, CHEST, BACK, ABDOMEN AND THIGHS. SEVERE ITCHING.  TREATED WITH BENADRYL AND CLARITIN. FADED OVER SEVERAL DAYS.  I HAVE NEVER HAD MORE THAN A 1 DAY SORE ARM FROM ANOTHER VACCINE.
Lack of efficacy. I have tested positive for COVID-19 on 03NOV2021, despite having been fully vaccinated.; Lack of efficacy. I have tested positive for COVID-19 on 03NOV2021, despite having been fully vaccinated.; This is a spontaneous report from a contactable consumer (patient). A 42-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EL3247) via an unspecified route of administration on 28Jan2021 (at the age of 42 years old) as dose 1, single and second dose on BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EL3247) via an an unspecified route of administration on 17Feb2021 (at the age of 42 years old) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. The patient had known allergies that was food intolerances (wheat, eggs). Concomitant medications included Claritine (LORATADINE) from an unspecified date for an unknown indication while SUDAFED (PSEUDOEPHEDRINE HYDROCHLORIDE) from an unspecified date for seasonal allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had been tested for COVID-19. On 01Nov2021 the patient experienced lack of efficacy. I have tested positive for COVID-19 on 03NOV2021, despite having been fully vaccinated. The patient underwent lab tests and procedures which included SARS-CoV-2 test (Nasal Swab, PCR) resulted in positive on 02Nov2021. The patient did not receive any treatment for the events. The outcome of the events was recovering.
This non-serious spontaneous case, initially received from other non-health professional on 02-Nov-2018, concerns a 65-year-old, elderly patient of an unspecified gender. It was reported that, the FLUCELVAX QIVc vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius. On 16-Oct-2018, the patient was administered FLUCELVAX QIVc [route of administration: intramuscular, anatomical location: left deltoid, batch number: 252230, expiry date: 31-May-2019 and dose: not reported] which underwent temperature excursion. At the time of this report, no adverse event was reported. This case 201805464 was crossed linked to original cases 201804863 due to same reporter.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Information regarding the patient's medical history was not provided. On 15-OCT-2012 the patient was vaccinated with two doses of VAQTA (dose, route and lot number was not reported for both doses). No other co-suspects were reported. No concomitant medications were reported. The patient had received two doses of VAQTA instead of one dose of VAQTA and one dose of RECOMBIVAX. No adverse effects were reported. No treatment information was reported. Additional information has been requested.
Paleness and bruising easily, thrombocytopenia, pancytopenia, severe aplastic anemia.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021 at 9:39 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 31-Mar-2021 at 9:39 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 37.72.  Concomitant products were not provided.  On 31-Mar-2021, Excursion time was 08AM temperature was 32 total doses given for the day was 199, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 31-Mar-2021. 4 vials were sent to clinic. Vaccine BUD date was 22-Apr-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (altered vision), RENAL PAIN (right side kidney flank  pain), VOMITING (vomiting), HEADACHE (headache) and NAUSEA (nausea) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 065F21A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Pfizer vaccine.Past adverse reactions to the above products included Muscle ache with Pfizer vaccine.On 19-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Nov-2021, the patient experienced VISUAL IMPAIRMENT (altered vision). On 20-Nov-2021, the patient experienced VOMITING (vomiting) and NAUSEA (nausea). On an unknown date, the patient experienced RENAL PAIN (right side kidney flank  pain) and HEADACHE (headache). At the time of the report, VISUAL IMPAIRMENT (altered vision), RENAL PAIN (right side kidney flank  pain), VOMITING (vomiting) and HEADACHE (headache) outcome was unknown and NAUSEA (nausea) had resolved.For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.No Concomitant medication were provided.No Treatment medication were provided. Patient reports some side effects to the Pfizer vaccine. Patient reports muscle aches.  Patient says Moderna vaccine had more symptoms. The patient received her booster Moderna Covid-19 vaccine on 19NOV2021 lot number 065F21A expiration date  is not provided. Patient received the vaccine in her right arm. The patient has a headache and altered vision. Patient reports nausea and vomiting on Saturday 20NOV2021 The patient reports right side kidney flank pain. Patient does not any longer experience nausea and no longer.
Weakness on the right side of his body. Touch makes right side of body sweat. Numbness in belly area. Loss of use of right hand. Pt is right handed.
A non-serious spontaneous report of difficulty breathing, vaccination error and "rash on his ears, face and feet" has been received from a nurse practitioner concerning a 28-month-old male, subsequent to H1N1, Intranasal. The patient had a history of asthma. No concomitant medications were reported. On 27-Oct-2009, the patient received H1N1, Intranasal for an unknown indication. On 04-Nov-2009, the patient experienced difficulty breathing. On an unknown date, he had "a rash on his ears, face and feet," which was in presence when he returned to the clinic on 04-Nov-2009. The outcome of the reported events was unknown. This is a corrected report to the previous report: vaccination error was added as a non-serious event; event start date were corrected. The corrected information was incorporated into the narrative.
Redness, swelling, warmth, given Keflex and Medrol dose pack